Details

NameSymbolSector
AURO LABORATORIES LTD.AUROLABPharmaceuticals
Open
274
High
274
Low
259.15
Close
265
Volume
4037
Exchange
bse
Time
14/08

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Auro Laboratories is  
None
Estimated Stoploss of Auro Laboratories is ₹  
274
Auro Laboratories has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Auro Laboratories is  
Unpredictableℹ
. 

Trend

Auro Laboratories is in  
Downtrendℹ
. 
Price of Auro Laboratories is  
Downℹ
 by  

2.02

%. 
Target
Buy @ 

252

Sell @ 

272

Volume

The trade volumes of Auro Laboratories have become  
Deficientℹ
The volume trend for Auro Laboratories is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Auro Laboratories is  

Down

 by  

27.88

% 

Valuation

The current market price of Auro Laboratories is  
Overvaluedℹ

Financials

Balance
The balance sheet of Auro Laboratories is:  

Balanced

Cashflow
Auro Laboratories has  
Insufficientℹ
 cash flow because there is  

Shortage

 of  

₹ 1cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

10.87% i.e. ₹ 5cr earned in operatingℹ
52.17% i.e. ₹ 24cr spent in investingℹ
36.96% i.e. ₹ 17cr earned in financingℹ
0% in otherℹ
Auro Laboratories has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

24% i.e. ₹ 18cr earned in operatingℹ
50.67% i.e. ₹ 38cr spent in investingℹ
25.33% i.e. ₹ 19cr earned in financingℹ
0% in otherℹ
Income
The income of Auro Laboratories is  

₹ 3cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Auro Laboratories Losses increased by:  

0

% and Income is Down by:  

57.14

% 

(*Jun 2025)

The income of Auro Laboratories is  

₹ 7cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Auro Laboratories Losses increased by:  

0

% and Income is Up by:  

133.33

% 

(*Mar 2025)

The income of Auro Laboratories is  

₹ 3cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Auro Laboratories Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.